Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 2,307	$ 120
Operating expenses
Selling, general and administrative	9,148	563
Research and development	6,794	3,644
Cost of goods sold	179
Total operating expenses	16,121	4,207
Loss from operations	(13,814)	(4,087)
Other income (expense)
Change in fair value of convertible promissory notes		(1,165)
Interest income	15
Interest expense	(58)	(224)
Total other expense, net	(43)	(1,389)
Loss before income tax expense	(13,857)	(5,476)
Net loss	$ (13,857)	$ (5,476)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.66)	$ (2.15)
Weighted average number of common shares outstanding used in computing net loss per share attributable to common stockholders, basic and diluted	20,914,842	2,542,358
Product Sales, Net [Member]
Revenue	$ 2,307
Grant [Member]
Revenue		$ 120